Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CONCERT PHARMACEUTICALS, INC. (CNCE) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/07/2022 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results Company Plans to Submit NDA in First Half of 2023 for Deuruxolitinib in Adults with Moderate to Severe Alopecia Areata"
08/04/2022 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results CTP-543 Positive Topline Results Reported in THRIVE-AA1 and THRIVE-AA2 Phase 3 Studies in Alopecia Areata",
"Creating New Possibilities for Patients to Live Their Lives August 2022"
05/05/2022 8-K Quarterly results
11/09/2021 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update"
08/05/2021 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results CTP-543 Phase 3 Program On Track to Support NDA Filing in Early 2023"
11/05/2020 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Company Update"
08/06/2020 8-K Quarterly results
04/30/2020 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Update on Clinical Programs Conference Call Scheduled Today at 8:30 a.m. ET"
11/07/2019 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Company Update Conference Call Scheduled Today at 8:30 a.m. ET"
08/01/2019 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Company Update Conference Call Scheduled Today at 8:30 a.m. EDT"
05/02/2019 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports First Quarter 2019 Financial Results Conference Call Scheduled Today at 8:30 a.m. ET"
02/28/2019 8-K Quarterly results
11/01/2018 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Company Update Conference Call Scheduled Today at 8:30 a.m. ET"
08/02/2018 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Company Update -- Clinical Programs Advance with CTP-543 Phase 2a Topline Data in Alopecia Areata and CTP-692 Phase 1 Trial Initiation Expected in the Fourth Quarter of 2018 -- -- Conference Call Scheduled Today at 8:30 a.m. EDT --"
05/03/2018 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports First Quarter 2018 Financial Results Conference Call Scheduled Today at 8:30 a.m. EDT"
03/01/2018 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Year Ended 2017 Financial Results CTP-543 On Track to Report Topline Phase 2a Results in Alopecia Areata by Year-End New Neuropsychiatric Product Candidate Poised to Enter Clinical Development in 2018 Conference Call Scheduled Today at 8:30 a.m. ET"
11/09/2017 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update Conference Call Scheduled Today at 8:30 a.m. EST"
08/08/2017 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Company Update Conference Call Scheduled Today at 8:30 a.m. EDT"
05/02/2017 8-K Form 8-K - Current report
03/06/2017 8-K Form 8-K - Current report
11/08/2016 8-K Form 8-K - Current report
08/09/2016 8-K Form 8-K - Current report
05/05/2016 8-K Form 8-K - Current report
03/01/2016 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Fourth Quarter and Year Ended 2015 Financial Results - Focus on Clinical Program Advancement in 2016 - - CTP-656 Solid Dose Phase 1 Results Confirmed Superior Pharmacokinetic Profile to Kalydeco® - - Conference Call Scheduled Today at 8:30 a.m. ET -"
11/05/2015 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Company Update Conference Call Scheduled Today at 8:30 a.m. EST"
08/05/2015 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Company Update"
05/08/2015 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports First Quarter 2015 Financial Results"
02/27/2015 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Year End 2014 Financial Results"
11/12/2014 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Update on CTP-354 Program"
08/12/2014 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update"
05/14/2014 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports First Quarter 2014 Financial Results"
04/01/2014 8-K Quarterly results
Docs: "Concert Pharmaceuticals Reports Year End 2013 Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy